생체흡수성 폴리머 시장 : 제품 유형, 형태, 제조 공정, 재료 유형, 용도, 최종사용자별 - 세계 예측(2025-2030년)

The Bioresorbable Polymers Market was valued at USD 998.48 million in 2024 and is projected to grow to USD 1,101.03 million in 2025, with a CAGR of 10.51%, reaching USD 1,819.30 million by 2030.

Bioresorbable polymers represent a cutting-edge frontier in the biomedical and manufacturing sectors, offering a unique combination of biodegradability and functionality. In recent years, these materials have gained significant importance as the demand for sustainable and patient-friendly solutions in healthcare and advanced manufacturing has increased. The inherent properties of bioresorbable polymers allow them to safely degrade within the body, eliminating the need for surgical removal and reducing long-term complications. This innovation is not only revolutionizing medical procedures but also paving the way for new possibilities in drug delivery systems, tissue engineering, and medical implants.

The evolution of bioresorbable polymers has been accelerated by rapid advancements in material science, increased R&D investments, and a growing emphasis on patient-centric healthcare solutions. Manufacturing processes have also become more sophisticated, ensuring that the performance, reliability, and safety of these materials meet stringent regulatory standards. With emerging applications in sectors such as controlled drug release, cardiovascular and orthopedic implant technology, and regenerative medicine, this market is poised to establish a transformative impact on both clinical outcomes and production efficiencies.

This executive summary presents a comprehensive overview of the current market dynamics, supported by deep-dive analyses into product innovations, segmentation studies, and regional growth trends. As the landscape of bioresorbable polymers continues to evolve, understanding the key drivers, challenges, and opportunities becomes essential for stakeholders seeking a competitive edge in this dynamic market.

Transformative Shifts in the Market Landscape

The landscape of the bioresorbable polymers market is undergoing transformative shifts driven by technological innovations, evolving regulatory frameworks, and changing healthcare demands. Recent breakthroughs in polymer chemistry and processing techniques have expanded the applications of these materials, making them versatile enough for a host of modern medical and industrial applications. Traditional materials are now being supplemented or replaced by bioresorbable options, ensuring safer and more efficient outcomes, particularly in areas where long-term material presence can pose a risk.

Advancements in manufacturing processes have streamlined production, reduced costs, and enabled higher precision in fabricating polymers with desirable degradation profiles. Stakeholders are now witnessing a shift from conventional extraction and processing techniques to more sustainable methods that emphasize efficiency and biocompatibility. At the same time, the global push for environmentally conscious products is influencing how materials are selected and developed, further accelerating the integration of bioresorbable polymers in a variety of sectors.

Market players are leveraging these changes by investing heavily in R&D to refine product performance and by forming strategic partnerships to commercialize innovative solutions. The transformation is also evident in the regulatory landscape, where enhanced safety guidelines ensure that bioresorbable products meet the highest standards for patient care. This environment of change, driven by both scientific and economic imperatives, sets the stage for a competitive market where successful adaptation can lead to significant rewards.

Key Segmentation Insights for Market Analysis

The bioresorbable polymers market is intricately segmented based on various parameters that together frame a multi-dimensional view of the sector's opportunities. A deep evaluation by product reveals that innovations are being developed across fibers, films, micro-particles, and nanomaterials, each offering distinctive properties for specific applications. Analysis based on form further categorizes these materials into liquid, powder, and solid, highlighting the versatility needed to meet diverse industrial and healthcare requirements.

In addition, a careful review of manufacturing processes such as blow molding, extrusion, and injection molding sheds light on how production techniques are tailored to optimize the performance of these polymers. Depending on the manufacturing method, the end product may exhibit varying characteristics that are crucial for its application, whether that be in a high-precision medical implant or a controlled drug release mechanism.

Material type serves as another important segmentation angle, with classifications into polyanhydrides, polycaprolactone (PCL), polyglycolic acid (PGA), polyhydroxyalkanoate (PHA), and polylactic acid (PLA). Each of these materials presents a unique set of properties in terms of degradability and mechanical strength, influencing their suitability for a range of specialized tasks in medical device manufacturing and regenerative medicine.

When examining applications, it becomes clear that bioresorbable polymers are pivotal in drug delivery systems, medical implants, tissue engineering, and wound healing devices. A closer look reveals further granularity; for instance, drug delivery systems are optimized as controlled release formulations and target-specific vehicles, while medical implants are designed with specialized features for cardiovascular stents and orthopedic implants. Similarly, tissue engineering benefits from scaffold designs and stem cell scaffolding techniques, and wound healing devices incorporate adhesive solutions and bandaging materials to enhance patient recovery. Exploring the end-user dimension, the market stretches across biotechnology companies, hospitals and clinics, pharmaceutical companies, and research institutes. This segmentation framework allows for targeted strategy development and reflects the diverse range of applications and technological intricacies within the bioresorbable polymers market.

Based on Product, market is studied across Fibers, Films, Micro-Particles, and Nanomaterials.

Based on Form, market is studied across Liquid, Powder, and Solid.

Based on Manufacturing Process, market is studied across Blow Molding, Extrusion, and Injection Molding.

Based on Material Type, market is studied across Polyanhydrides, Polycaprolactone (PCL), Polyglycolic Acid (PGA), Polyhydroxyalkanoate (PHA), and Polylactic Acid (PLA).

Based on Application, market is studied across Drug Delivery Systems, Medical Implants, Tissue Engineering, and Wound Healing Devices. The Drug Delivery Systems is further studied across Controlled Release Formulations and Target-Specific Vehicles. The Medical Implants is further studied across Cardiovascular Stents and Orthopedic Implants. The Tissue Engineering is further studied across Scaffold Designs and Stem Cell Scaffolding. The Wound Healing Devices is further studied across Adhesive Solutions and Bandaging Materials.

Based on End-User, market is studied across Biotechnology Companies, Hospitals and Clinics, Pharmaceutical Companies, and Research Institutes.

Key Regional Insights and Growth Opportunities

The global market for bioresorbable polymers can be characterized by its regional diversity, with significant growth observed in the Americas, Europe, Middle East & Africa, and the Asia-Pacific regions. In the Americas, advanced healthcare systems and robust research infrastructure foster an environment conducive to the rapid adoption of innovative bioresorbable solutions. This region benefits from established manufacturing capabilities and strong governmental support, all of which accelerate market penetration and infrastructural development.

Europe, Middle East & Africa offer a unique blend of stringent regulatory demands and meticulous quality controls that drive innovation in bioresorbable materials. The region is marked by an increasing focus on sustainability, which aligns with the environmentally friendly nature of these polymers, spurring both industrial and clinical research initiatives.

Asia-Pacific stands out as a dynamic market driven by fast-paced technological advancements and an expanding consumer base. Strong government initiatives supporting research and development, combined with rapidly growing healthcare and biotechnology sectors, have positioned the region as a hub for both innovation and manufacturing. These regional advantages are instrumental in shaping the future trajectory of the market, as industry players tailor their strategies to cater to the specific needs and regulatory frameworks of each area.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Catalyzing Market Innovation

The bioresorbable polymers market is marked by the strategic maneuvers of several leading companies that are driving innovation and setting benchmarks for performance. Industry pioneers such as 3D Biotek LLC and Acuro Organics Limited have been instrumental in advancing the product portfolio by investing in state-of-the-art production techniques. Global players like Advanced Polymer Materials Inc. and Anhui Jumei Biological Technology Co., Ltd. continue to push the boundaries in development, taking a holistic approach to integrate research with market needs.

Established entities like Ashland Inc. and Avantium N.V. have demonstrated robust capabilities in both capturing and expanding market share, while BMG Incorporated and CD Bioparticles focus on niche applications that address specific clinical challenges. Companies such as Corbion NV and Evonik Industries AG are well-known for their commitment to quality and innovation, consistently refining the properties of bioresorbable polymers to meet more critical demand spikes. This drive for excellence is further bolstered by the contributions of Foster Corporation, Futerro Group, and Galatea Surgical, Inc., whose strategies are oriented towards combining creative engineering with regulatory compliance.

Huizhou Foryou Medical Devices Co., Ltd., Koninklijke DSM N.V., and MAST Biosurgery provide comprehensive solutions that have resulted in increased efficacy and greater patient safety. Meanwhile, Merck KGaA, Mitsui & Co., Ltd., and Nanosoft Polymers continue to strengthen their market positions by leveraging decades of expertise to foster innovation and productivity. Notably, Nomisma Healthcare Pvt. Ltd., Otto Chemie Pvt. Ltd., and Poly-Med Incorporated maintain a steadfast focus on application-specific solutions, underpinning their offerings with thorough research and robust production methods. With a dynamic mix of established and emerging players such as PolyNovo Limited, Polysciences, Inc., Putnam Plastics, and REVA Medical, LLC, the landscape remains highly competitive and ripe with opportunities for further innovation. Rivika Bio Industries Pvt. Ltd., SEQENS SAS, Solanyl Biopolymers Inc., SpecialChem S.A., Stahl Holdings B.V., Torise Biomaterials Co.,Ltd., UBQ Materials Ltd., Vibha Ecopac Pvt Ltd., and Zeus Industrial Products, Inc. collectively illustrate the scale and diversity of the market, each leveraging their unique strengths to address evolving customer needs and industry trends.

The report delves into recent significant developments in the Bioresorbable Polymers Market, highlighting leading vendors and their innovative profiles. These include 3D Biotek LLC, Acuro Organics Limited, Advanced Polymer Materials Inc., Anhui Jumei Biological Technology Co., Ltd., Ashland Inc., Avantium N.V., BMG Incorporated, CD Bioparticles, Corbion NV, Evonik Industries AG, Foster Corporation, Futerro Group, Galatea Surgical, Inc., Huizhou Foryou Medical Devices Co., Ltd., Koninklijke DSM N.V., MAST Biosurgery, Merck KGaA, Mitsui & Co., Ltd., Nanosoft Polymers, Nomisma Healthcare Pvt. Ltd., Otto Chemie Pvt. Ltd., Poly-Med Incorporated, PolyNovo Limited, Polysciences, Inc., Putnam Plastics, REVA Medical, LLC, Rivika Bio Industries Pvt. Ltd., SEQENS SAS, Solanyl Biopolymers Inc., SpecialChem S.A., Stahl Holdings B.V., Torise Biomaterials Co.,Ltd., UBQ Materials Ltd., Vibha Ecopac Pvt Ltd., and Zeus Industrial Products, Inc.. Actionable Recommendations for Industry Leaders

Industry leaders are encouraged to closely monitor emerging trends and invest in R&D initiatives that focus on enhancing product performance and manufacturing efficiency. Strategic collaborations and partnerships across sectors are essential to tap into diverse applications and to respond swiftly to ever-changing regulatory environments. Emphasizing customer-centric design and robust quality assurance practices will further strengthen market positioning in this competitive landscape. Leaders should also prioritize sustainability and compliance, ensuring that each step in the development cycle aligns with best practices while maximizing patient safety and environmental impacts.

Conclusion and Future Outlook

In conclusion, the market for bioresorbable polymers is at an exciting inflection point, characterized by rapid technological advancement and expanding applications across diverse sectors. The increasing adoption of innovative manufacturing processes, coupled with targeted segmentation strategies, is paving the way for sustainable and clinically effective solutions. As industry leaders continue to leverage new research and adapt to evolving regulatory frameworks, the future of bioresorbable polymers appears promising, with clear pathways for growth and innovation. Continuous improvements in material science and production methodology are expected to further bolster the market's potential, making this a fertile ground for investment and strategic expansion.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing usage of bioresorbable sutures and implants in surgical procedures
    • 5.1.1.2. Growing adoption of bioresorbable polymers for polymeric drug delivery and 3D printed medical implants
    • 5.1.1.3. Favorable reimbursement policies for several surgical procedures
  • 5.1.2. Restraints
    • 5.1.2.1. Limited availability of raw materials for the production of bioresorbable polymers
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing advancements in innovative orthopedic implants and surgical devices
    • 5.1.3.2. Supportive government initiatives in research and development of bio-based bioresorbable polymer
  • 5.1.4. Challenges
    • 5.1.4.1. Technical limitations and performance issues in bioresorbable polymers
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Increasing preference for bioresorbable polymer fibers in medical sutures and tissue engineering
  • 5.2.2. Application: Expanding application of bioresorbable polymers in tissue engineering
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Bioresorbable Polymers Market, by Product

• 6.1. Introduction
• 6.2. Fibers
• 6.3. Films
• 6.4. Micro-Particles
• 6.5. Nanomaterials

7. Bioresorbable Polymers Market, by Form

• 7.1. Introduction
• 7.2. Liquid
• 7.3. Powder
• 7.4. Solid

8. Bioresorbable Polymers Market, by Manufacturing Process

• 8.1. Introduction
• 8.2. Blow Molding
• 8.3. Extrusion
• 8.4. Injection Molding

9. Bioresorbable Polymers Market, by Material Type

• 9.1. Introduction
• 9.2. Polyanhydrides
• 9.3. Polycaprolactone (PCL)
• 9.4. Polyglycolic Acid (PGA)
• 9.5. Polyhydroxyalkanoate (PHA)
• 9.6. Polylactic Acid (PLA)

10. Bioresorbable Polymers Market, by Application

• 10.1. Introduction
• 10.2. Drug Delivery Systems
  • 10.2.1. Controlled Release Formulations
  • 10.2.2. Target-Specific Vehicles
• 10.3. Medical Implants
  • 10.3.1. Cardiovascular Stents
  • 10.3.2. Orthopedic Implants
• 10.4. Tissue Engineering
  • 10.4.1. Scaffold Designs
  • 10.4.2. Stem Cell Scaffolding
• 10.5. Wound Healing Devices
  • 10.5.1. Adhesive Solutions
  • 10.5.2. Bandaging Materials

11. Bioresorbable Polymers Market, by End-User

• 11.1. Introduction
• 11.2. Biotechnology Companies
• 11.3. Hospitals and Clinics
• 11.4. Pharmaceutical Companies
• 11.5. Research Institutes

12. Americas Bioresorbable Polymers Market

• 12.1. Introduction
• 12.2. Argentina
• 12.3. Brazil
• 12.4. Canada
• 12.5. Mexico
• 12.6. United States

13. Asia-Pacific Bioresorbable Polymers Market

• 13.1. Introduction
• 13.2. Australia
• 13.3. China
• 13.4. India
• 13.5. Indonesia
• 13.6. Japan
• 13.7. Malaysia
• 13.8. Philippines
• 13.9. Singapore
• 13.10. South Korea
• 13.11. Taiwan
• 13.12. Thailand
• 13.13. Vietnam

14. Europe, Middle East & Africa Bioresorbable Polymers Market

• 14.1. Introduction
• 14.2. Denmark
• 14.3. Egypt
• 14.4. Finland
• 14.5. France
• 14.6. Germany
• 14.7. Israel
• 14.8. Italy
• 14.9. Netherlands
• 14.10. Nigeria
• 14.11. Norway
• 14.12. Poland
• 14.13. Qatar
• 14.14. Russia
• 14.15. Saudi Arabia
• 14.16. South Africa
• 14.17. Spain
• 14.18. Sweden
• 14.19. Switzerland
• 14.20. Turkey
• 14.21. United Arab Emirates
• 14.22. United Kingdom

15. Competitive Landscape

• 15.1. Market Share Analysis, 2024
• 15.2. FPNV Positioning Matrix, 2024
• 15.3. Competitive Scenario Analysis
  • 15.3.1. Sonavex Inc. raises USD 15 million in Series A-2 funding
  • 15.3.2. The POLYMEER initiative, funded with EUR 4.9 million by the circular bio-based Europe joint undertaking HORIZON program
  • 15.3.3. Ashland completes its second expansion of the Viatel bioresorbable polymers manufacturing and R&D lab
  • 15.3.4. Evonik and BellaSeno advance commercialization of 3D-printed, bioresorbable implants
  • 15.3.5. Evonik backs Allay's development of pain therapy implants
  • 15.3.6. Collagen matrix acquires polyganics
  • 15.3.7. Technip energies acquires Biosuccinium technology from DSM for bio-sourced and fully biodegradable polymers production
  • 15.3.8. Ashland expands bioresorbable development site in Ireland
  • 15.3.9. Biotech startup String Bio raises $20M in funding from Woodside Energy Group, others
  • 15.3.10. Amerigo scientific launches polycaprolactone for bioprinting
• 15.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3D Biotek LLC
• 2. Acuro Organics Limited
• 3. Advanced Polymer Materials Inc.
• 4. Anhui Jumei Biological Technology Co., Ltd.
• 5. Ashland Inc.
• 6. Avantium N.V.
• 7. BMG Incorporated
• 8. CD Bioparticles
• 9. Corbion NV
• 10. Evonik Industries AG
• 11. Foster Corporation
• 12. Futerro Group
• 13. Galatea Surgical, Inc.
• 14. Huizhou Foryou Medical Devices Co., Ltd.
• 15. Koninklijke DSM N.V.
• 16. MAST Biosurgery
• 17. Merck KGaA
• 18. Mitsui & Co., Ltd.
• 19. Nanosoft Polymers
• 20. Nomisma Healthcare Pvt. Ltd.
• 21. Otto Chemie Pvt. Ltd.
• 22. Poly-Med Incorporated
• 23. PolyNovo Limited
• 24. Polysciences, Inc.
• 25. Putnam Plastics
• 26. REVA Medical, LLC
• 27. Rivika Bio Industries Pvt. Ltd.
• 28. SEQENS SAS
• 29. Solanyl Biopolymers Inc.
• 30. SpecialChem S.A.
• 31. Stahl Holdings B.V.
• 32. Torise Biomaterials Co.,Ltd.
• 33. UBQ Materials Ltd.
• 34. Vibha Ecopac Pvt Ltd.
• 35. Zeus Industrial Products, Inc.